Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 10/20 | 0.58 |
| ▸ | ITGAV | P06756 | 10/20 | 0.58 |
| ▸ | ITGB5 | P18084 | 6/20 | 0.58 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.58 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.56 |
| ▸ | ITGB6 | P18564 | 2/20 | 0.56 |
| ▸ | KDM4A | O75164 | 1/20 | 0.55 |
| ▸ | CTSG | P08311 | 2/20 | 0.55 |
| ▸ | KRAS | P01116 | 1/20 | 0.54 |
| ▸ | MC4R | P32245 | 6/20 | 0.53 |
| ▸ | MC5R | P33032 | 6/20 | 0.53 |
| ▸ | MC3R | P41968 | 6/20 | 0.53 |
| ▸ | MC1R | Q01726 | 6/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclorgdfv SCHEMBL19605449 | 1.00 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| Cyclorgdfv SCHEMBL19605549 | 1.00 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| Cyclorgdfv SCHEMBL25474158 | 1.00 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL25473422 | 0.94 | KDM4A (0.55) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL20888358 | 0.93 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL21766911 | 0.93 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL19605458 | 0.93 | ITGB3 (0.58) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL22970200 | 0.90 | ITGB3 (0.56) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL20888349 | 0.90 | ITGB3 (0.52) | ITGB3ITGAVITGB5ITGB1ITGA5 | |
| SCHEMBL19605463 | 0.90 | MC4R (0.57) | ITGB3ITGAVITGB5ITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036218-B2 | Modulators of airway basal cells for the treatment or prevention of lung diseases | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2024-07-16 | — | — | US | claimed |
| EP-4731273-A2 | HYDROGEL FORMULATIONS AND METHODS OF USE THEREOF | Tempo Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260007802-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | TEMPO THERAPEUTICS INC (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4654940-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | Tempo Therapeutics, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025006482-A2 | HYDROGEL FORMULATIONS AND METHODS OF USE THEREOF | TEMPO THERAPEUTICS, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024159142-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | TEMPO THERAPEUTICS, INC. (US) | 2024-08-02 | — | — | WO | disclosed |
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007802-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | VCL, CD44, FGB | ITGB3 460/4885ITGAV 664/4885ITGB5 820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.